BackBio-Rad Laboratories Overview

Bio-Rad Laboratories Other Current Assets

Bio-Rad Laboratories's other current assets is $180M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$179.60M

Peer average / median

Loading

Bio-Rad Laboratories Other Current Assets History

Loading

Bio-Rad Laboratories vs. peers: Other Current Assets Comparison

Loading

Bio-Rad Laboratories Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bio-Rad Laboratories (BIO) FAQ

Bio-Rad Laboratories (BIO) currently reports a other current assets of $180M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Bio-Rad Laboratories's other current assets history and peer comparisons.

Bio-Rad Laboratories's other current assets changed from $0 to $180M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bio-Rad Laboratories reported $180M in other current assets as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bio-Rad Laboratories, and consider following BIO for alerts when major investors trade the stock.

Bio-Rad Laboratories is classified in the Healthcare sector. On other current assets, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIO with unrelated industries.